tclmeelmo
Joined 10 years ago
Joined 10 years ago
The pictures of the car in a article linked elsewhere in this discussion (https://www.ksl.com/?sid=39727592&nid=148&title=utah-man-say...) show that the windshield was smashed. I'm finding it challenging to reconcile your personal example with the images of the smashed windshield; in my own experience, it takes some effort to break laminated safety glass. I would think (perhaps wrongly) that it would take more effort to break safety glass than would be stopped by a 1in. step.
> but I don't think there's much room to discuss safety here.
I couldn't disagree more. I don't understand why it should be possible to disable any safety interlock (at least, that's how I'm interpreting the feature description) in a consumer product, especially persistently.
I'm not familiar with them, nor do I have access, but I'm hoping someone here might be helpful on either aspect. Specifically, I'm wondering if the standards for automatic transmission controls recommend against having the Park setting do anything beyond activating the parking pawl and parking brake (when electronically controlled).
For VC firms that are experienced in the biomedical space, Theranos changes nothing because they were already suspicious of Theranos.
For firms that are inexperienced in the biomedical space, they have hopefully learned that growth cannot compensate for flaws in science or technology. If they continue to invest in biomedical, they will be much more careful in their DD; or perhaps they lose their appetite for biomedical and leave entirely.
I don't think things have changed for biomedical startups that are based on good science and technology and have an experienced team.
What would be wonderful is if the media learned a lesson from this mess. As I see it, they were a passenger in the Theranos hype machine.